Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | University of Dundee |
| Country | United Kingdom |
| Start Date | Jan 28, 2021 |
| End Date | Jan 27, 2026 |
| Duration | 1,825 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 220321 |
The Type VI secretion system (T6SS) is used by many Gram-negative bacteria to deliver toxic ‘effector’ proteins into rival bacterial cells as a means of inter-bacterial competition.
The T6SS likely plays a central role in shaping many polymicrobial communities, but important aspects of effector delivery and action in target cells, and the ‘real-life’ relevance of T6SSs in a clinical context remain elusive.
We will investigate the journey of individual and co-operating groups of effectors, from their recruitment by the T6SS to their fate and action in targeted cells, and dissect the mechanism of individual anti-bacterial effectors.
We will also consider the global availability and mobility of anti-bacterial effectors and how the T6SS and its effectors can influence bacterial success in a clinical context.
Using multidisciplinary approaches, we aim to: - Determine the mechanism of toxicity of novel anti-bacterial effectors - Elucidate the fate of effectors inside target cells - Define mechanisms of versatile effector recruitment and delivery in attacker cells - Use genomics to reveal the diversity, evolution and real-life relevance of T6SS effectors Our findings, combining mechanistic detail with insight into biological relevance, will provide fundamental advances in our understanding of T6SS-mediated anti-bacterial activity and may inform future strategies to counter bacterial pathogens.
University of Dundee
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant